Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: COUGHING UP PHLEGM; GENERAL COLD-LIKE SYMPTOMS; SWELLING AT INJECTION SITE; This spontaneous report received from a patient concerned a male of unspecified age. The patient''s height, and weight were not reported. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: UNKNOWN) dose was not reported, administered on 22-JUN-2021 for prophylactic vaccination. No concomitant medications were reported. On JUN-2021, the subject experienced swelling at injection site. On 02-JUL-2021, the subject experienced coughing up phlegm. On 02-JUL-2021, the subject experienced general cold-like symptoms. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from swelling at injection site, and had not recovered from coughing up phlegm, and general cold-like symptoms. This report was non-serious.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166